Axovant Sciences CEO: Biggest Biotech IPO Ever | Mad Money | CNBC
With a new Alzheimer’s drug, it's is the company everyone is talking about. Is it the real deal?
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about Axovant Sciences here: http://www.cnbc.com/id/102753274
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news: http://madmoney.cnbc.com
Watch full episodes: http://bit.ly/MadMoneyEpisodes
Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter
Like Mad Money on Facebook: http://bit.ly/LikeMadMoney
Follow Cramer on Twitter: http://bit.ly/FollowCramer
Connect with CNBC News Online!
Visit CNBC.com: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
Axovant Sciences CEO: Biggest Biotech IPO Ever | Mad Money | CNBC
Видео Axovant Sciences CEO: Biggest Biotech IPO Ever | Mad Money | CNBC канала CNBC
» Subscribe to CNBC: http://cnb.cx/SubscribeCNBC
» Watch more Mad Money here: http://bit.ly/WatchMadMoney
» Read more about Axovant Sciences here: http://www.cnbc.com/id/102753274
"Mad Money" takes viewers inside the mind of one of Wall Street's most respected and successful money managers. Jim Cramer is your personal guide through the confusing jungle of Wall Street investing, navigating through both opportunities and pitfalls with one goal in mind -- to try to help you make money.
About CNBC: From 'Wall Street' to 'Main Street' to award winning original documentaries and Reality TV series, CNBC has you covered. Experience special sneak peeks of your favorite shows, exclusive video and more.
Get More Mad Money!
Read the latest news: http://madmoney.cnbc.com
Watch full episodes: http://bit.ly/MadMoneyEpisodes
Follow Mad Money on Twitter: http://bit.ly/MadMoneyTwitter
Like Mad Money on Facebook: http://bit.ly/LikeMadMoney
Follow Cramer on Twitter: http://bit.ly/FollowCramer
Connect with CNBC News Online!
Visit CNBC.com: http://www.cnbc.com/
Find CNBC News on Facebook: http://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: http://cnb.cx/FollowCNBC
Follow CNBC News on Google+: http://cnb.cx/PlusCNBC
Follow CNBC News on Instagram: http://cnb.cx/InstagramCNBC
Axovant Sciences CEO: Biggest Biotech IPO Ever | Mad Money | CNBC
Видео Axovant Sciences CEO: Biggest Biotech IPO Ever | Mad Money | CNBC канала CNBC
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
STRICTLYVC - Vivek Ramaswamy, CEO & Founder of Roivant SciencesBuilding A Biotech | ForbesVivek Ramaswamy breaks down ESG alternative fund 'Strive' backed by Thiel, AckmanBioMarin Pharmaceutical CEO: Close to a Cure? | Mad Money | CNBCLIVE: CNBC Marathon - Documentaries and deep dives 24/7Interview With Airbnb CEO Brian Chesky | FortuneGo Public or Go Home: The Pros and Cons of IPOsBioMarin Pharmaceutical CEO: Treating Hemophilia | Mad Money | CNBCHow To Identify A Multi-Crore Business Idea? | Ridhima Arora | Josh TalksHow To Mine Monero (CPU & GPU)Why The U.S. Mortgage Market Is BrokenHow Elon Musk's Twitter Takeover Plans Shook Wall Street And Social MediaWhy Americans Are So Stressed About MoneyWhat Is The Future Of Hydropower?How to Buy IPO Stocks — and WhenHow Walmart Is Betting Big On Stores To Catch Amazon In E-commerceWhere Inflation Is Worst In The U.S.Stop Mixing Consumerism With Morality With Vivek Ramaswamy On MSNBCWhy genomics is the next big AI/Tech opportunity!How the U.S. Space Force Plans to Police The Private Space Boom